MedPath

SOMAVERT

SOMAVERT

Approved
DIN Number

02272210

Drug Class

Human

Market Date

Jan 24, 2006

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02272210
AIG Number0151545003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
H01AX01 PEGVISOMANT
Product Specifications
Dosage FormKit ,  Powder For Solution
Route of AdministrationSubcutaneous
AHFS Classification68:30.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PEGVISOMANTActive
Strength: 20 MG / VIAL
Monograph: PEGVISOMANT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.